Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolus (EOLS) Research & Development (2018 - 2025)

Evolus' Research & Development history spans 8 years, with the latest figure at $3.5 million for Q4 2025.

  • For Q4 2025, Research & Development rose 43.25% year-over-year to $3.5 million; the TTM value through Dec 2025 reached $9.6 million, up 4.4%, while the annual FY2025 figure was $9.6 million, 4.4% up from the prior year.
  • Research & Development reached $3.5 million in Q4 2025 per EOLS's latest filing, up from $2.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $3.5 million in Q4 2025 to a low of $301000.0 in Q3 2021.
  • Average Research & Development over 5 years is $1.6 million, with a median of $1.6 million recorded in 2022.
  • The largest YoY upside for Research & Development was 357.14% in 2022 against a maximum downside of 44.35% in 2022.
  • A 5-year view of Research & Development shows it stood at $423000.0 in 2021, then surged by 218.68% to $1.3 million in 2022, then skyrocketed by 76.56% to $2.4 million in 2023, then grew by 2.1% to $2.4 million in 2024, then surged by 43.25% to $3.5 million in 2025.
  • Per Business Quant, the three most recent readings for EOLS's Research & Development are $3.5 million (Q4 2025), $2.0 million (Q3 2025), and $1.8 million (Q2 2025).